Minims Tropicamide 0,5 mℓ Eye Drops
PDF Leaflet Revision Date: 20 August 1981
Clinical Summary
Quick overview from the medicine insert
Indication
Mydriasis and cycloplegia of rapid onset and brief duration.
Dosage (summary)
Adults: 2 drops at 5 min intervals; may repeat 1-2 drops after 30 mins.
Onset of Action / Duration
Onset: 15-30 mins, Duration: <1-4 hours
Contraindications
- Narrow angle between iris and cornea
Common side effects
- Photophobia
- Conjunctival irritation
- Dry mouth
- Bradycardia
- Tachycardia
Counselling Points
- Use once and discard
- Store between 2-8 u00b0C
- Keep out of reach of children
Serious warnings
- Systemic toxicity can occur, especially in children
Important Disclaimer
The Minims Tropicamide 0,5 mℓ Eye Drops professional information leaflet below is the property of Soflens and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
Clinical Particulars
Section 4 of the official insert — extracted exactly as issued, no alterations
4.1 Therapeutic indications
Tropicamide is indicated when mydriasis and cyloplegia of rapid onset and brief duration are required.
4.2 Posology and method of administration
Adults: 2 drops at 5 minute intervals, with a further 1 or 2 drops after 30 minutes if required. Children: At the discretion of the ophthalmologist.
4.3 Contraindications
Tropicamide should not be used in patients with a narrow angle between the iris and cornea.
4.4 Special warnings and precautions for use
Photophobia; may cause conjunctival irritation in sensitive persons. Although absorption into the bloodstream from the conjunctival sac is minimal systemic toxicity can occur, particularly in small children. Such side-effects include dryness of the mouth with difficulty in swallowing, bradycardia followed by tachycardia.
4.9 Overdose
Toxic effects include tachycardia, and depressant and stimulant action of the central nervous system. Physostigmine salicylate 1- 2 mg should be injected subcutaneously, intra-muscularly or intravenously to control toxic effects. Locally, mydriatic effects may be counteracted by the instillation of pilocarpine eye drops, 1 % to 4 %.
